ABINGDON, VA. — This is an official press release from the U.S. Department of Justice (USAO - Virginia, Western), published as received.
ABINGDON, Va. – A pair of Maryland men who conspired with Dr. Rotimi Iluyomade, an Annandale-based doctor convicted of distributing more than 7,000 oxycodone pills, 34,000 milliliters of hydrocodone-chlorpheniramine solution (also known as “tussionex”), and 107,000 milliliters of promethazine-codeine solution (“also known as lean”), pled guilty recently in U.S. District Court in Abingdon.
Obioma Alozie Ndubuka, 32, a.k.a. “Bank Roll” of Derwood, Maryland, and Raymono Alfonzo Russell II, 25, of Bowie, Maryland, pled guilty recently to one count of conspiracy to distribute and possess with the intent to distribute Schedule II controlled substances and to acquire promethazine-codeine solution by fraud. In addition, Russell was ordered to forfeit $40,000 to the United States.
Also charged in the conspiracy are Cameron Isaiah Lewis, 23, of Bowie, Maryland; Elhadj Malick Diallo, 31, of Silver Spring, Maryland; Zion Oluwademilade Adeduwon, 24, of Bowie, Maryland; Kenechukwu Brian Okwara, a.k.a. “Kene,” 29 of Bowie, Maryland; and Yared Michael Tesfaye, a.k.a. “Yar,” 28, of Montgomery Village, Maryland.
Adeduwon pled guilty in 2025 and has been ordered to forfeit $100,000 to the United States.
According to court documents, in at least 2023 and 2024, Iluyomade and the co-conspirators entered into an agreement to distribute more than 7,000 oxycodone pills and more than 34,000 milliliters of hydrocodone-chlorpheniramine solution to pharmacies in multiple states, including California, Colorado, Nebraska, Arizona, Missouri, Florida, Pennsylvania, Maryland, New Jersey, Delaware, Rhode Island, Georgia, Wisconsin, Texas, West Virginia, and in the Eastern and Western Districts of Virginia. At least 70 of the illegal controlled substance prescriptions were transmitted to and/or filled at pharmacies in the Western District of Virginia.
As part of the conspiracy, multiple individuals visited Iluyomade’s medical clinic to obtain fraudulent prescriptions. The individuals provided Iluyomade with lists of multiple “patients” with fake identifying information or different variations of names and false addresses, and requested prescriptions be sent to pharmacies throughout the United States for the “patients” on the lists.
Ndubuka traveled to various pharmacies to pick up fraudulent prescriptions written by Iluyomade, which he then distributed for profit, often posting pictures on his social media accounts to facilitate drug sales. Iluyomade transmitted at least 134 fraudulent prescriptions using variations of patient names using the “Ndubuka” surname. The prescriptions listed 56 different residential addresses but the same patient home phone number.
Russell visited Iluyomade’s clinic to obtain fraudulent prescriptions, paying approximately $300 per fraudulent prescription and often using the personal information of homeless individuals to obtain the prescriptions. He paid these individuals cash, or provided them drugs, to go inside the pharmacy and pick up the fraudulent prescriptions. Russell then distributed the drugs he obtained for profit.
The investigation began on September 2, 2023, when Russell attempted to pick up a fraudulent promethazine-codeine solution prescription transmitted by Dr. Iluyomade at TigerX Pharmacy in Honaker, Virginia. Russell was arrested and a search of his vehicle revealed multiple controlled substance prescription bottles in various ‘patient’ names, all from Dr. Iluyomade, filled at pharmacies in Roanoke, Radford, Tazewell, and Floyd, Virginia.
The Drug Enforcement Administration, Federal Bureau of Investigation, Virginia State Police, Russell County Sheriff’s Office, Salisbury, Maryland Police Department, Loudoun County Sheriff’s Office, Nebraska State Police, HHS-OIG, and the Food and Drug Administration (FDA) are investigating the case.
Assistant U.S. Attorneys Lena Busscher and Randy Ramseyer are prosecuting the case.
Acting United States Attorney Robert N. Tracci, Christopher C. Goumenis, Special Agent in Charge DEA Washington Division, and Darren B. Cox, Assistant Director in Charge of the FBI Washington Field Office made the announcement.
